Fentanyl test strips are saving lives, but that's just the beginning.

Published Date: 16 Feb 2023

Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.

Read Full News

Latest News

UAE Expat MDs Stay Put as Conflict Drags On

In a country where expats dominate the medical workforce, many doctors are staying despite drone strikes, citing stability and feeling responsible for their patients.

AstraZeneca Drug Reduces Flare-ups Of Chronic Lung Disease in Late-stage Trials

AstraZeneca's experimental drug tozorakimab reduced flare-ups of chronic obstructive pulmonary disease in two late-stage trials, sending its shares up as ⁠much as 3.8% on...

Spotting the Signs of Postpartum Psychosis

Postpartum psychosis can be better detected, treated, and even prevented.

Violent Parental Death Raises Mortality Risk in Kids

Parental death from violent or preventable causes may signal a need for earlier, targeted interventions to reduce downstream health risks in children.

Injectable Buprenorphine Shows Promise in Pregnancy

A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

Novel Blood Marker Can Differentiate Infection From Colitis

The monocyte distribution width derived from routine blood testing can distinguish bacterial enterocolitis from acute severe ulcerative colitis.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Latest News

In a country where expats dominate the medical workforce, many doctors are staying despite drone strikes, citing stability and feeling responsible for their patients.

AstraZeneca's experimental drug tozorakimab reduced flare-ups of chronic obstructive pulmonary disease in two late-stage trials, sending its shares up as ⁠much as 3.8% on...

Postpartum psychosis can be better detected, treated, and even prevented.

Parental death from violent or preventable causes may signal a need for earlier, targeted interventions to reduce downstream health risks in children.

A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.

The monocyte distribution width derived from routine blood testing can distinguish bacterial enterocolitis from acute severe ulcerative colitis.

News All Time

Cosmetic Surgery Investigation Prompts Warnings for Patients

An investigation into cosmetic surgery chains prompts warnings from plastic surgeons and calls for transparency in how doctors are investigated.

Bloody Urine in the ED? Early Imaging May Improve Outcomes

Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying diagnosis and worsening outcomes.

Prenatal Tylenol Use Drops, Leucovorin Prescriptions Surge

Prenatal Tylenol Use Drops, Leucovorin Prescriptions Surge

Meningitis Risk for Young Adults With Chikungunya Vaccine

European safety committee advises product information update after review of a safety signal for aseptic meningitis following Ixchiq vaccination against chikungunya.

Doctors Tell MPs Corridor Care Is Driving Abuse of NHS Staff

Emergency doctors warned MPs that unsafe A&E conditions and corridor care are leaving staff exposed to rising violence.

Is the US Entering a ‘Fifth Wave’ of the Overdose Crisis?

Experts suggest an increase in stimulant use may signal a ‘fifth wave’ of the US overdose crisis.

Opioid Risk Score Falls Short in External Study

A validation study raises concerns about an Epic risk score for opioids used in primary care.

Med Students Who Don’t Match Turn to SOAP — What to Expect

Medical students going through Match will learn on March 16 whether they matched to a residency program. For those who don’t, the process of SOAP begins.

Deprivation and Age Drive Paediatric ED Visits

Children and young individuals who frequently visit EDs over 2 years are often from the most deprived areas; infants show greater variations in reasons for ED visits than older children.

Match Brings Double Joy for Twins Who Joined Same Program

Anesthesiologists Danielle Kerr and Christine Kerr encourage medical students: ‘You will end up where you were meant to be.’

How Hospital Medicine Is Poised to Evolve This Year

Changes are coming, but this remains true: Hospitalists will be asked for more as their expertise grows.

French Probe Finds No Link Between Baby Death, Nestlé Formula

A judicial inquiry launched in France after the death ⁠of a baby has shown no link with the recalled Nestle infant ⁠formula he had consumed, the Bordeaux prosecutor said.

First-in-Class Tx for Dravet Syndrome Shows Early Success

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

Work Disability Risk Can Persist Years After TBI

Traumatic brain injury is linked to a persistently increased risk for work disability irrespective of the severity of the trauma, a new cohort study shows.

Could Red Light Help Tackle Resistant Klebsiella Pneumoniae?

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

Recommended News For You

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Research suggests peer support may lower depression, stress among cancer patients in low-resource settings

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

For elderly, unfit patients, the all-oral AML regimen shows promise.

According to JAMA, statin use may increase cancer-related survival in breast cancer patients.

Recommended Articles For You

The Importance of Balanced Potassium Levels in Maintaining Good Health 

Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era 

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v 

Navigating the Complexities of Melanoma Staging: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survivors of childhood brain cancer are more likely to be held back in school

2.

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

3.

Research uncovers hidden Australian skin cancer epidemic

4.

In 18 States, alcohol exclusion laws are still in effect.

5.

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

1.

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked

2.

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management

3.

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025

4.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

5.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

3.

Current Scenario of Cancer- Q&A Session to Close the Gap

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot